These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 27853526)

  • 21. Review: advances in non-invasive prenatal diagnosis.
    Vaiopoulos AG; Athanasoula KC; Papantoniou N; Kolialexi A
    In Vivo; 2013; 27(2):165-70. PubMed ID: 23422474
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent advances of genomic testing in perinatal medicine.
    Peters DG; Yatsenko SA; Surti U; Rajkovic A
    Semin Perinatol; 2015 Feb; 39(1):44-54. PubMed ID: 25444417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Noninvasive detection of fetal subchromosomal abnormalities by semiconductor sequencing of maternal plasma DNA.
    Yin AH; Peng CF; Zhao X; Caughey BA; Yang JX; Liu J; Huang WW; Liu C; Luo DH; Liu HL; Chen YY; Wu J; Hou R; Zhang M; Ai M; Zheng L; Xue RQ; Mai MQ; Guo FF; Qi YM; Wang DM; Krawczyk M; Zhang D; Wang YN; Huang QF; Karin M; Zhang K
    Proc Natl Acad Sci U S A; 2015 Nov; 112(47):14670-5. PubMed ID: 26554006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Chorionic villus sampling and amniocentesis: invasive procedures and their risks in current prenatal diagnostic practice].
    Papp C; Tóth-Pál E; Beke A; Bán Z; Joó JG; Szigeti Z; Csaba A; Oroszné NJ; Papp Z
    Orv Hetil; 2004 Feb; 145(7):315-21. PubMed ID: 15049045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is nuchal translucency screening associated with different rates of invasive testing in an older obstetric population?
    Chasen ST; McCullough LB; Chervenak FA
    Am J Obstet Gynecol; 2004 Mar; 190(3):769-74. PubMed ID: 15042012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current landscape of prenatal genetic screening and testing.
    Krstić N; Običan SG
    Birth Defects Res; 2020 Mar; 112(4):321-331. PubMed ID: 31633301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Committee Opinion No. 581: the use of chromosomal microarray analysis in prenatal diagnosis.
    American College of Obstetricians and Gynecologists Committee on Genetics
    Obstet Gynecol; 2013 Dec; 122(6):1374-7. PubMed ID: 24264715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An Overview on Prenatal Screening for Chromosomal Aberrations.
    Hixson L; Goel S; Schuber P; Faltas V; Lee J; Narayakkadan A; Leung H; Osborne J
    J Lab Autom; 2015 Oct; 20(5):562-73. PubMed ID: 25587000
    [TBL] [Abstract][Full Text] [Related]  

  • 29. National decline in invasive prenatal diagnostic procedures in association with uptake of combined first trimester and cell-free DNA aneuploidy screening.
    Robson SJ; Hui L
    Aust N Z J Obstet Gynaecol; 2015 Oct; 55(5):507-10. PubMed ID: 26259499
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genomic medicine in prenatal diagnosis.
    South ST; Chen Z; Brothman AR
    Clin Obstet Gynecol; 2008 Mar; 51(1):62-73. PubMed ID: 18303500
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Value of detection of cell-free fetal DNA in maternal plasma in the prenatal diagnosis of chromosomal abnormalities].
    Wang SJ; Gao ZY; Lu YP; Li YL; You YQ; Zhang LW; Wang LX; Xu H
    Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):808-12. PubMed ID: 23302119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The safety and efficacy of chorionic villus sampling for early prenatal diagnosis of cytogenetic abnormalities.
    Rhoads GG; Jackson LG; Schlesselman SE; de la Cruz FF; Desnick RJ; Golbus MS; Ledbetter DH; Lubs HA; Mahoney MJ; Pergament E
    N Engl J Med; 1989 Mar; 320(10):609-17. PubMed ID: 2645520
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-invasive prenatal diagnosis by fetal nucleic acid analysis in maternal plasma: the coming of age.
    Chiu RW; Lo YM
    Semin Fetal Neonatal Med; 2011 Apr; 16(2):88-93. PubMed ID: 21075065
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reproductive decisions after fetal genetic counselling.
    Pergament E; Pergament D
    Best Pract Res Clin Obstet Gynaecol; 2012 Oct; 26(5):517-29. PubMed ID: 22809468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abortion for Fetal Genetic Abnormalities: Type of Abnormality and Gestational Age at Diagnosis.
    Grossman TB; Chasen ST
    AJP Rep; 2020 Jan; 10(1):e87-e92. PubMed ID: 32190411
    [No Abstract]   [Full Text] [Related]  

  • 36. Prenatal testing guidelines: time for a new approach.
    Kuppermann M; Norton ME
    Gynecol Obstet Invest; 2005; 60(1):6-10. PubMed ID: 15711084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prenatal diagnosis of congenital anomalies--present status and future problems].
    Suzumori K
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Aug; 40(8):1027-32. PubMed ID: 3075224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I data. National Institute of Child Health and Development Fetal Cell Isolation Study.
    Bianchi DW; Simpson JL; Jackson LG; Elias S; Holzgreve W; Evans MI; Dukes KA; Sullivan LM; Klinger KW; Bischoff FZ; Hahn S; Johnson KL; Lewis D; Wapner RJ; de la Cruz F
    Prenat Diagn; 2002 Jul; 22(7):609-15. PubMed ID: 12124698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetics: update on prenatal screening and diagnosis.
    Evans MI; Andriole S; Evans SM
    Obstet Gynecol Clin North Am; 2015 Jun; 42(2):193-208. PubMed ID: 26002161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How should costs and cost-effectiveness be considered in prenatal genetic testing?
    Sparks TN; Caughey AB
    Semin Perinatol; 2018 Aug; 42(5):275-282. PubMed ID: 30173949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.